Cohort characteristics: inflammatory and oxidative stress markers, adipokines and advanced glycation end products.

Central obesity: waist-to-height ration >0.5 [31]; elevated BP: systolic BP (SBP)≥130 mm Hg and/or diastolic BP (DBP)≥85 mm Hg; increased atherogenic risk: AIP≥0.11 [29]; and insulin resistance: QUICKIε-(carboxymethyl)lysine; Alb: albumin; AGE-Fl: advanced glycation end products associated fluorescence of plasma; AU: arbitrary units; AOPP: advanced oxidation protein products; sRAGE: soluble receptor for advanced glycation end products*: p**: p***: p+: p++: p+++: pitalics: statistical evaluation performed on logarithmically transformed dataCohort characteristics: inflammatory and oxidative stress markers, adipokines and advanced glycation end products.